Subscribe To
IOBT / IO Biotech to Present at the Jefferies Healthcare Conference
IOBT News
By GlobeNewsWire
September 6, 2023
IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating more_horizontal
By Zacks Investment Research
June 15, 2023
IO Biotech (IOBT) Down Despite Positive Update on Melanoma Study
IO Biotech (IOBT) falls 25% despite achieving the clinical milestone of enrolling 225 patients in the advanced melanoma study evaluating the IO102-IO1 more_horizontal
By GlobeNewsWire
May 30, 2023
IO Biotech to Present at the Jefferies Healthcare Conference
NEW YORK, May 30, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating c more_horizontal